153 related articles for article (PubMed ID: 26139648)
1. Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers.
Marchetto L; Sordino D; De Bernardo G; Trevisanuto D
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26139648
[TBL] [Abstract][Full Text] [Related]
2. Neonatal acute renal failure secondary to maternal exposure to telmisartan, angiotensin II receptor antagonist.
Pietrement C; Malot L; Santerne B; Roussel B; Motte J; Morville P
J Perinatol; 2003; 23(3):254-5. PubMed ID: 12732865
[TBL] [Abstract][Full Text] [Related]
3. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
Bos-Thompson MA; Hillaire-Buys D; Muller F; Dechaud H; Mazurier E; Boulot P; Morin D
Ann Pharmacother; 2005 Jan; 39(1):157-61. PubMed ID: 15590878
[TBL] [Abstract][Full Text] [Related]
4. Increased renal echogenicity in a preterm neonate. Kidneys with tubular dysplasia due to exposure to candesartan during pregnancy.
Bald M; Holder M; Zieger M; Vochem M; Leichter HE
Pediatr Nephrol; 2005 Nov; 20(11):1664-5, 1666-8. PubMed ID: 16082550
[No Abstract] [Full Text] [Related]
5. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
[TBL] [Abstract][Full Text] [Related]
6. Safety of olmesartan in a patient with telmisartan-induced myotoxicity: a case report.
Barvaliya MJ; Naik VN; Shah AC; Tripathi CR
Br J Clin Pharmacol; 2015 Jun; 79(6):1034-6. PubMed ID: 25495498
[No Abstract] [Full Text] [Related]
7. Telmisartan induced urticarial vasculitis.
Mahajan VK; Singh R; Gupta M; Raina R
Indian J Pharmacol; 2015; 47(5):560-2. PubMed ID: 26600649
[TBL] [Abstract][Full Text] [Related]
8. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
[TBL] [Abstract][Full Text] [Related]
9. ARBs for cardiovascular and renal protection in high-risk patients.
Aalbers J
Cardiovasc J Afr; 2011; 22(4):224. PubMed ID: 21881697
[No Abstract] [Full Text] [Related]
10. [Fetal toxicity of angiotensin-II receptor antagonists].
Payen V; Chemin A; Jonville-Béra AP; Saliba E; Cantagrel S
J Gynecol Obstet Biol Reprod (Paris); 2006 Nov; 35(7):729-31. PubMed ID: 17088776
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor antagonist treatment during pregnancy.
Alwan S; Polifka JE; Friedman JM
Birth Defects Res A Clin Mol Teratol; 2005 Feb; 73(2):123-30. PubMed ID: 15669052
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-II-receptor inhibitors in pregnancy.
Hinsberger A; Wingen AM; Hoyer PF
Lancet; 2001 May; 357(9268):1620. PubMed ID: 11386315
[No Abstract] [Full Text] [Related]
13. Angiotensin II receptor blockers in pregnancy: a report of five cases.
Gersak K; Cvijic M; Cerar LK
Reprod Toxicol; 2009 Jul; 28(1):109-12. PubMed ID: 19491003
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
Serebruany VL; Atar D; Hanley DF
Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
[No Abstract] [Full Text] [Related]
15. A third amlodipine/ARB combination (Twynsta) for hypertension.
Med Lett Drugs Ther; 2010 Jan; 52(1329):2-3. PubMed ID: 20208469
[No Abstract] [Full Text] [Related]
16. Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan.
Volpe M
Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):1061-72. PubMed ID: 23030295
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study.
Hoeltzenbein M; Tissen-Diabaté T; Fietz AK; Zinke S; Kayser A; Meister R; Weber-Schoendorfer C; Schaefer C
Clin Res Cardiol; 2018 Aug; 107(8):679-687. PubMed ID: 29574489
[TBL] [Abstract][Full Text] [Related]
18. [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].
Partosch F; Stahlmann R
Med Monatsschr Pharm; 2011 Oct; 34(10):358-62. PubMed ID: 22010419
[No Abstract] [Full Text] [Related]
19. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
Middeke M
Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
[No Abstract] [Full Text] [Related]
20. Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists.
Sinelli MT; Cattarelli D; Cortinovis S; Maroccolo D; Chirico G
Pediatr Med Chir; 2008; 30(6):306-8. PubMed ID: 19431954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
